Zacks Small Cap Research – MGRM: The De-Risking of the Monogram Story from FDA Clearance and Initiation of Live Patient Trials Supports Price Target of $6.00 – Go Health Pro

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 1st quarter 2025 financial results on May 14, 2025 which were largely in line with our expectations. Research and development expenses for the quarter were $2.26 million compared to $2.41 million in the prior year period. The R&D decrease was primarily … Read more

Zacks Small Cap Research – DEFT: 1Q25 Earnings Review: Adjusted EPS Miss on Higher Expenses; Raising on EPS Estimates/Price Target on Accelerating Momentum across the Franchise – Go Health Pro

By Michael Kim NASDAQ:DEFT READ THE FULL DEFT RESEARCH REPORT Pre-market open on 5/14/25, DeFi Technologies (NASDAQ:DEFT) reported 1Q25 earnings results. On an IFRS basis, DEFT reported net income per share of $0.08, or meaningfully above our $0.04 estimate. While mark-to-market noise makes actual vs. estimate analysis a bit more challenging, we note core revenue … Read more

Zacks Small Cap Research – GBLI: Improved Underwriting and Strong Premium Growth Supports Near-Term Price Target of $47.00 – Go Health Pro

By Thomas Kerr, CFA NYSE:GBLI READ THE FULL GBLI RESEARCH REPORT 1st Quarter 2025 Financial Results Global Indemnity Group (NYSE:GBLI) reported 1st quarter 2025 financial and operating results that showed the effects of the California wildfire losses which totaled $15.6 million ($12.2 million after-tax). Gross written premiums were $98.7 million and the net loss for … Read more

Malware scammers target HR professionals with Venom Spider malware – Go Health Pro

Malware scammers target HR professionals with Venom Spider malware – Go Health Pro

Threat actors are targeting organizations by disguising their malware payloads as resume submissions to human resources (HR) departments.The team at Arctic Wolf reported that a privately-run malware operation known as Venom Spider has been targeting HR professionals by way of phony resume submissions and fake personal websites pretending to be job seekers.The threat actors are … Read more

Zacks Small Cap Research – SDA: SunCar Technology’s Strong Growth Potential Supports Price Target of $13.00 – Go Health Pro

By Thomas Kerr, CFA NASDAQ:SDA READ THE FULL SDA RESEARCH REPORT 2024 Financial and Operating Results On April 28, 2025, SunCar (NASDAQ:SDA) released full year 2024 results which showed impressive revenue and EBITDA growth. Total company revenues increased 21% to $441.9 million for the full year 2024. This compares to $363.7 million in 2023. Auto … Read more